Skip to main content
. Author manuscript; available in PMC: 2017 Jun 22.
Published in final edited form as: Acta Neuropathol. 2016 Oct 4;133(1):121–138. doi: 10.1007/s00401-016-1626-1

Table 3.

Pathological features of all cases and controls grouped by clustering

Variables Blue cluster Yellow cluster Gray cluster Orange cluster p value
n 20 18 25 12
Diagnosisc <0.001a
 Controls 0 (0.0 %) 3 (16.7 %) 21 (84.0 %) 1 (8.3 %)
 PD cases 0 (0.0 %) 4 (22.2 %) 3 (12.0 %) 3 (25.0 %)
 ET cases 2 (10.0 %) 11 (61.1 %) 1 (4.0 %) 6 (50.0 %)
 MSA cases 9 (45.0 %) 0 (0.0 %) 0 (0.0 %) 1 (8.3 %)
 SCA1 cases 9 (45.0 %) 0 (0.0 %) 0 (0.0 %) 1 (8.3 %)
Purkinje cell counts 5.7 ± 2.2 Median = 5.4 7.9 ± 1.3 Median = 8.1 12.0 ± 1.5 Median = 11.7 10.7 ± 1.8 Median = 10.1 <0.001b
Torpedo counts 77.6 ± 67.6 Median = 50.5 12.7 ± 7.7 Median = 15.0 5.1 ± 7.7 Median = 3.0 9.6 ± 6.50 Median = 8.5 <0.001b
CF synaptic density (puncta/100 μm) 16.9 ± 3.3 Median = 17.0 21.9 ± 3.1 Median = 22.00 24.8 ± 3.7 Median = 24.00 18.5 ± 1.2 Median = 18.00 <0.001b
Percentage of CF extending into outer 20 % ML 9.7 ± 9.4 Median = 6.0 25.9 ± 4.9 Median = 26.0 16.5 ± 5.6 Median = 17.0 23.1 ± 12.1 Median = 22.8 <0.001b

Values represent mean ± standard deviation or number (percentage), and for variables with non-normal distribution, the median is reported as well

CF climbing fiber, ET essential tremor, ML molecular layer, MSA multiple system atrophy, PD Parkinson’s disease, SCA1 spinocerebellar ataxia type 1, VGlut2 vesicular glutamate transporter

a

Chi-square test

b

Kruskal–Wallis test

c

The percentages indicate column percentages